---
title: "Roth MKM Sticks to Its Buy Rating for Tecogen (TGEN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286424700.md"
description: "Roth MKM analyst Chip Moore has maintained a Buy rating for Tecogen (TGEN) with a price target of $10.00. Moore, who specializes in the Industrials sector, has an impressive average return of 39.2% and a 60.15% success rate on his stock recommendations. Tecogen currently holds a Strong Buy consensus among analysts, with a price target consensus of $7.25."
datetime: "2026-05-14T13:22:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286424700.md)
  - [en](https://longbridge.com/en/news/286424700.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286424700.md)
---

# Roth MKM Sticks to Its Buy Rating for Tecogen (TGEN)

Roth MKM analyst Chip Moore reiterated a Buy rating on Tecogen today and set a price target of $10.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Moore covers the Industrials sector, focusing on stocks such as Generac Holdings, Powell Industries, and Tecogen. According to TipRanks, Moore has an average return of 39.2% and a 60.15% success rate on recommended stocks.

Tecogen has an analyst consensus of Strong Buy, with a price target consensus of $7.25.

### Related Stocks

- [TGEN.US](https://longbridge.com/en/quote/TGEN.US.md)
- [GNRC.US](https://longbridge.com/en/quote/GNRC.US.md)
- [POWL.US](https://longbridge.com/en/quote/POWL.US.md)

## Related News & Research

- [Tecogen Reports First Quarter 2026 Financial Results | TGEN Stock News](https://longbridge.com/en/news/286163303.md)
- [Tecogen (TGEN) Gets a Buy from Craig-Hallum](https://longbridge.com/en/news/282553656.md)
- [Do Wall Street Analysts Like Xylem Stock?](https://longbridge.com/en/news/286924489.md)
- [Stifel Nicolaus Sticks to Their Buy Rating for Target Hospitality (TH)](https://longbridge.com/en/news/286494923.md)
- [Oppenheimer Keeps Their Buy Rating on Protara Therapeutics (TARA)](https://longbridge.com/en/news/286430766.md)